The Aerolineas Argentinas plane that brought from the Russian Federation a consignment of 400 thousand doses of the Sputnik V vaccine against the coronavirus landed at the Ezeiza airport at 19:08 today (Fri 12 Feb 2021).
Arriving at the beginning of next week from India, 580,000 doses of the Covishield vaccine, manufactured in India, would arrive in the country.to cover all health workers and begin to vaccinate people over 70 years, explained González García,
“it will allow the vaccination of the prioritized groups to be scaled up."
The Indian vaccine is a variant of the Oxford vaccine.
Last Tuesday, the Ministry of Health of the Nation authorized with an “emergency” character the Covishield vaccine. It is the "COVISHIELD / ChAdOx1nCoV-19 Corona Virus Vaccine - Recombinant vaccine produced by the Serum Institute of India", in collaboration with the University of Oxford and AstraZeneca, in the context of a technology transfer.
The vaccine is given in two doses, four to 12 weeks apart . It can be safely stored at temperatures of approximately 2 ° C to 8 ° C, the same as a household refrigerator, and can be administered in existing healthcare settings. International clinical trials of the Oxford-AstraZeneca vaccine showed that when people received a half dose and then a full dose, the effectiveness reached 90% .
Sputnik V: arribó el avión de Aerolíneas Argentinas procedente de Moscú con una nueva partida de vacunas
Sputnik V: arribó el avión de Aerolíneas Argentinas procedente de Moscú con una nueva partida de vacunas
www.lanacion.com.ar
Arriving at the beginning of next week from India, 580,000 doses of the Covishield vaccine, manufactured in India, would arrive in the country.to cover all health workers and begin to vaccinate people over 70 years, explained González García,
“it will allow the vaccination of the prioritized groups to be scaled up."
Coronavirus: Estiman que la semana que viene llegan las vacunas de AstraZeneca desde la India
Coronavirus: Estiman que la semana que viene llegan las vacunas de AstraZeneca desde la India
www.lanacion.com.ar
Last Tuesday, the Ministry of Health of the Nation authorized with an “emergency” character the Covishield vaccine. It is the "COVISHIELD / ChAdOx1nCoV-19 Corona Virus Vaccine - Recombinant vaccine produced by the Serum Institute of India", in collaboration with the University of Oxford and AstraZeneca, in the context of a technology transfer.
The vaccine is given in two doses, four to 12 weeks apart . It can be safely stored at temperatures of approximately 2 ° C to 8 ° C, the same as a household refrigerator, and can be administered in existing healthcare settings. International clinical trials of the Oxford-AstraZeneca vaccine showed that when people received a half dose and then a full dose, the effectiveness reached 90% .